Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$6.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 31 most recent Form 4 transactions.
| 3,300 |
| $4.98 |
| $16.4K |
| +0.5% |
| Open the original filing on SEC.gov |
| Jul 30 | NXTC | NextCure, Inc. | PBUY | 77,850 | $4.96 | $385.8K | +12.8% | Open the original filing on SEC.gov |
| Jul 30 | NXTC | NextCure, Inc. | PBUY | 100,000 | $4.90 | $490K | +19.7% | Open the original filing on SEC.gov |
| Jul 30 | NXTC | NextCure, Inc. | PBUY | 25,000 | $4.81 | $120.3K | +5.2% | Open the original filing on SEC.gov |
| Jul 30 | NXTC | NextCure, Inc. | PBUY | 20,000 | $5.00 | $100K | +4.3% | Open the original filing on SEC.gov |
| Jul 30 | NXTC | NextCure, Inc. | PBUY | 20,000 | $5.00 | $100K | +4.5% | Open the original filing on SEC.gov |
| Jul 30 | NXTC | NextCure, Inc. | PBUY | 50,000 | $4.97 | $248.6K | +12.7% | Open the original filing on SEC.gov |
| Jul 29 | NXTC | NextCure, Inc. | PBUY | 1,600 | $5.00 | $8K | +0.4% | Open the original filing on SEC.gov |
| Jul 29 | NXTC | NextCure, Inc. | PBUY | 1,810 | $5.00 | $9.1K | +0.5% | Open the original filing on SEC.gov |
| Jul 28 | NXTC | NextCure, Inc. | PBUY | 6,400 | $4.95 | $31.7K | +1.7% | Open the original filing on SEC.gov |
| Jul 27 | NXTC | NextCure, Inc. | PBUY | 7,798 | $5.00 | $39K | +2.1% | Open the original filing on SEC.gov |
| Jul 15 | INM | InMed Pharmaceuticals Inc. | PBUY | 1,000 | $1.56 | $1.6K | +0.1% | Open the original filing on SEC.gov |
| May 19 | RLYB | Rallybio Corp | PBUY | 200 | $13.80 | $2.8K | +<0.1% | Open the original filing on SEC.gov |
| May 19 | RLYB | Rallybio Corp | PBUY | 10,000 | $13.98 | $139.8K | +1.1% | Open the original filing on SEC.gov |
| May 19 | INM | InMed Pharmaceuticals Inc. | PBUY | 200,000 | $1.50 | $299.8K | +33.3% | Open the original filing on SEC.gov |
| May 19 | INM | InMed Pharmaceuticals Inc. | PBUY | 200,000 | $1.56 | $312.1K | +50.0% | Open the original filing on SEC.gov |
| May 19 | INM | InMed Pharmaceuticals Inc. | PBUY | 68,551 | $1.60 | $109.7K | +20.7% | Open the original filing on SEC.gov |
| May 18 | RLYB | Rallybio Corp | PBUY | 6,009 | $13.98 | $84K | +0.7% | Open the original filing on SEC.gov |
| May 15 | RLYB | Rallybio Corp | PBUY | 200 | $13.95 | $2.8K | +<0.1% | Open the original filing on SEC.gov |
| May 15 | RLYB | Rallybio Corp | PBUY | 100 | $13.80 | $1.4K | +<0.1% | Open the original filing on SEC.gov |
| May 13 | RLYB | Rallybio Corp | PBUY | 75,178 | $14.00 | $1.1M | +9.0% | Open the original filing on SEC.gov |
| May 13 | RLYB | Rallybio Corp | PBUY | 4,081 | $13.80 | $56.3K | +0.5% | Open the original filing on SEC.gov |
| May 12 | RLYB | Rallybio Corp | PBUY | 800 | $13.83 | $11.1K | +0.1% | Open the original filing on SEC.gov |
| May 11 | RLYB | Rallybio Corp | PBUY | 19,900 | $14.00 | $278.6K | +2.5% | Open the original filing on SEC.gov |
| May 11 | RLYB | Rallybio Corp | PBUY | 25,000 | $14.00 | $350K | +3.2% | Open the original filing on SEC.gov |
| May 11 | RLYB | Rallybio Corp | PBUY | 5,100 | $14.00 | $71.4K | +0.7% | Open the original filing on SEC.gov |
| May 5 | RLYB | Rallybio Corp | PBUY | 35,101 | $14.00 | $491.3K | +4.7% | Open the original filing on SEC.gov |
| May 4 | RLYB | Rallybio Corp | PBUY | 116,904 | $13.97 | $1.6M | +18.6% | Open the original filing on SEC.gov |
| May 4 | RLYB | Rallybio Corp | PBUY | 3,900 | $13.90 | $54.2K | +0.6% | Open the original filing on SEC.gov |